由p38γ MAPK在S595处的CARM1酸化驱动了ROS介导的细胞衰老
1Muscle Physiome Research Center and Research Institute of Pharmaceutical Sciences, Sookmyung Women's University, Seoul, 04310, Republic of Korea; College of Pharmacy, Sookmyung Women's University, Seoul, 04310, Republic of Korea.
Redox biology
|September 12, 2024
概括
CARM1调节线粒体动力学和ROS的产生. 抑制细胞质CARM1可能为消除癌症和衰老细胞提供新的策略.
科学领域:
- 线粒体生物学 线粒体生物学
- 细胞衰老 细胞衰老
- 癌症研究 癌症研究
背景情况:
- CARM1 (协活性剂相关的阿金氨基甲基转移酶1) 主要是核的.
- 它通过基因表达调节影响线粒体平衡.
- 氧化应激触发了CARM1的细胞质转移.
研究的目的:
- 研究CARM1在线粒体动力学和细胞衰老中的作用.
- 探索CARM1抑制剂在癌症和衰老细胞中的治疗潜力.
主要方法:
- 研究了在氧化应激下CARM1的局部化和功能.
- 分析了CARM1与DRP1.1等线粒体蛋白的相互作用.
- 评估了CARM1抑制剂对癌症和衰老细胞增殖和亡的影响.
主要成果:
- CARM1抑制了线粒体生物发生并促进了裂变.
- 氧化应激诱导细胞质CARM1转位,增强ROS的产生和促进衰老.
- CARM1抑制剂减少癌细胞的增殖,并诱导衰老细胞的亡.
结论:
- 细胞质CARM1通过改变线粒体动力学和增加ROS,促进细胞衰老.
- 向细胞质功能的CARM1抑制剂为癌症和衰老细胞消除提供了有前途的治疗策略.
相关概念视频
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


